Cibus (NASDAQ:CBUS - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($1.12) earnings per share for the quarter, missing analysts' consensus estimates of ($1.01) by ($0.11), Zacks reports. Cibus had a negative net margin of 14,729.06% and a negative return on equity of 22.70%. The company had revenue of $0.55 million for the quarter, compared to the consensus estimate of $0.40 million. During the same quarter in the previous year, the business earned ($5.45) EPS.
Cibus Stock Down 0.6 %
Shares of CBUS traded down $0.11 during mid-day trading on Friday, reaching $17.74. The company had a trading volume of 50,516 shares, compared to its average volume of 61,022. The stock has a market capitalization of $383.59 million, a P/E ratio of -0.78 and a beta of 1.99. The stock has a 50 day moving average of $18.50 and a two-hundred day moving average of $16.63. Cibus has a 52-week low of $8.90 and a 52-week high of $38.85.
Analyst Upgrades and Downgrades
Separately, HC Wainwright reiterated a "buy" rating and set a $25.00 price target on shares of Cibus in a research note on Friday.
Check Out Our Latest Stock Report on CBUS
About Cibus
(
Get Free Report)
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cibus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cibus wasn't on the list.
While Cibus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
